Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-01-15 Sale | 2020-01-17 4:10 pm | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $65.27 | $981,205 | 303,699 (Direct) | View |
2020-01-07 Sale | 2020-01-09 4:10 pm | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 13,931 | $60.1 | $837,308 | 343,037 (Direct) | View |
2020-01-02 Sale | 2020-01-06 4:15 pm | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 16,137 | $58.55 | $944,872 | 179,309 (Direct) | View |
2019-12-12 Sale | 2019-12-13 5:00 pm | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $60 | $902,040 | 195,446 (Direct) | View |
2019-12-09 Sale | 2019-12-11 4:30 pm | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $55 | $826,870 | 432,607 (Direct) | View |
2019-12-03 Sale | 2019-12-05 4:20 pm | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $50 | $751,763 | 225,514 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2020-01-15 Exercise | 2020-01-17 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $3.95 | 303,699 (Direct) | View |
2020-01-15 Exercise | 2020-01-17 4:10 pm | N/A 2026-10-20 | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $0 | 303,699 (Direct) | View |
2020-01-07 Exercise | 2020-01-09 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 13,931 | $3.95 | 343,037 (Direct) | View |
2020-01-07 Exercise | 2020-01-09 4:10 pm | N/A 2026-10-20 | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 13,931 | $0 | 343,037 (Direct) | View |
2020-01-02 Exercise | 2020-01-06 4:15 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 16,137 | $3.95 | 179,309 (Direct) | View |
2020-01-02 Exercise | 2020-01-06 4:15 pm | N/A 2026-10-20 | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 16,137 | $0 | 179,309 (Direct) | View |
2019-12-12 Exercise | 2019-12-13 5:00 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $3.95 | 195,446 (Direct) | View |
2019-12-12 Option Award | 2019-12-13 5:00 pm | N/A 2026-10-20 | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $0 | 195,446 (Direct) | View |
2019-12-09 Exercise | 2019-12-11 4:30 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $3.95 | 432,607 (Direct) | View |
2019-12-09 Option Award | 2019-12-11 4:30 pm | N/A 2026-10-20 | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $0 | 432,607 (Direct) | View |
2019-12-03 Option Award | 2019-12-05 4:20 pm | N/A 2026-10-20 | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $0 | 225,514 (Direct) | View |
2019-12-03 Exercise | 2019-12-05 4:20 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $0 | 225,514 (Direct) | View |